A recent study showed that mouth taping, as mimicked by closing the mouth in people with sleep apnea, may not be the cure-all ...

The primary treatment for people with moderate or severe OSA is ... Tongue trainer: In 2021, the Food and Drug Administration ...

Sleep apnoea affects many older Australians — but managing it isn’t as difficult or expensive as you might think.

Sleep apnea is a condition that many people mistake or ignore, even though it stands to have serious repercussions on the ...

Mouth tape is often a simple, non-invasive method of promoting nasal breathing, which can result in a more peaceful, restful ...

The randomized trial linked Livanova’s aura6000 to improvements on measures of OSA severity and blood oxygen after six months of treatment ... its device but said the company “may have a difficult ...

VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders (including ...

Air Voel believes in sleep health, offering cutting-edge CPAP devices that are reliable and adjustable for restful sleep. Air Voel allows people to manage their health with innovative technology, ...

LivaNova today announced that its OSPREY trial of nerve stimulation for treating sleep apnea met its primary endpoints.

Revenue Increased 17% Quarter over QuarterOperating Loss Decreased 27% Management to Host Conference Call Today at 5:00 pm ETLITTLETON, Colo., ...

Researchers released new clinical guidelines for treating restless legs syndrome (RLS), emphasizing patient-centered care and ...

A key player in the market, Apnea Sciences Corporation contributes to innovative solutions that address the diverse causes of snoring. Its commitment to research and development positions it as a ...